Hutch News

Hutch News

Stories tagged 'hvtn'

'Cautiously optimistic' about HIV vaccines

A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey

Nov. 30, 2018 | By Sabin Russell / Fred Hutch News Service

In advance of World AIDS Day on Dec. 1, former Fred Hutch President and Director Dr. Larry Corey said he is "cautiously optimistic" about the current HIV vaccine trials. A renowned virologist, Corey has been a pioneer in HIV research since the beginning of the pandemic.

View story >


The pride of Fred Hutch

HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade

June 7, 2018 | By Mary Engel / Fred Hutch News Service

During Pride Month, a parade of honors is in store for HIV Vaccine Trials Network veteran Steven Wakefield, external relations director for the Fred Hutch–based global group.

View story >


Meet Peru's HIV superhero

By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic

Jan. 22, 2018 | By Mary Engel / Fred Hutch News Service

A leader in Peru's battle against HIV/AIDS, Dr. Jorge Sanchez's superpower is research. He is working with the Fred Hutch-based HIV Vaccine Trials Network on a potentially landmark prevention study.

View story >


New 'mosaic' HIV vaccine study launched for World AIDS Day

As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic

Dec. 1, 2017 | By Mary Engel / Fred Hutch News Service

The HIV Vaccine Trials Network is having a banner year. Last month in South Africa, the network launched a clinical trial called the Imbokodo Study to test an experimental vaccine regimen designed to protect against HIV subtypes around the world. Over the coming months, the Imbokodo study will roll out in four other southern African countries.

View story >


Insights from infants could inform HIV vaccine design

Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV

Nov. 27, 2017 | By Sabrina Richards / Fred Hutch News Service

Infant immune responses to HIV could provide clues to help build protective or therapeutic HIV vaccines.

View story >


Enlisting the microbiome in the quest for an AIDS vaccine

We now know that microbial communities, especially in our guts, profoundly affect immune response

Nov. 22, 2017 | By Sabin Russell / Fred Hutch News Service

Scientists at Fred Hutch are studying how the microbiome alters the immune system’s response to vaccines. Their work is already providing new insights on interactions between microbes in the body and the immune system that have implications for improving many types of vaccines.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.